Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Meghan Shekar
Observed institutions:
Boston Children's Hospital,
Houston Methodist,
Baylor College of Medicine,
Dana-Farber Cancer Institute,
Texas Children's Hospital
ORCID:
0000-0002-6711-9896
Observed ORCID:
0000-0002-6711-9896
OpenAlex ID:
A5073797473
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors
2024
·
Frank Y. Lin
, Austin Stuckert
, et al.
·
Journal of Clinical Oncology
·
83
PDF
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors
2024
·
Anne Miller
, Rachel Daum
, et al.
·
Cytotherapy
·
12
Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation
2025
·
Priya Mahajan
, Sarah Beth May
, et al.
·
Pediatric Blood & Cancer
·
2
ALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature
2023
·
Meghan Shekar
, Gabriela Llaurador Caraballo
, et al.
·
Biomedicines
·
2
PDF
Standardizing the evaluation and management of iron deficiency anemia secondary to heavy menstrual bleeding in the emergency department
2024
·
Josaura Fernandez Sanchez
, Luisanna M. Sánchez
, et al.
·
Pediatric Blood & Cancer
·
1
PDF
Phase I Trial of GD2.CAR T Cells Combined with a Novel Interleukin-7 Signal Modulator
2022
·
Bilal Omer
, Thomas Shum
, et al.
·
Transplantation and Cellular Therapy
·
1
Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors
2026
·
Frank Y. Lin
, Austin Stuckert
, et al.
·
Journal of Clinical Oncology
Daratumumab as a Toxicity‐Sparing Agent During Frontline Treatment of T‐Cell Acute Lymphoblastic Leukemia
2025
·
Meghan Shekar
, Linda Zhang
, et al.
·
Pediatric Blood & Cancer
PDF
Exth-47. Enhancing Gd2.cart Therapy for Diffuse Midline Glioma With Lsd1 and Hdac Inhibitors
2024
·
Rebecca Murdaugh
, Meghan Shekar
, et al.
·
Neuro-Oncology
PDF
Immu-18. Enhancing Gd2.car T Cell Therapy for Diffuse Midline Glioma With Lsd1 and Hdac Inhibitors
2024
·
Rebecca L Murdaugh
, Meghan Shekar
, et al.
·
Neuro-Oncology
PDF
Spinal cord compression: An unusual sequela of sickle cell disease
2022
·
Meghan Shekar
, Gina Casini
, et al.
·
Pediatric Blood & Cancer
Show more works
View as search
Works count:
11
Citation count:
101
H-index:
2
I10-index:
2
Year
Topic
Type
